Janus Henderson Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.17B | Sell |
|
|||||
2025
Q1 | $1.35B | Sell |
|
|||||
2024
Q4 | $1.14B | Buy |
|
|||||
2024
Q3 | $1.17B | Buy |
|
|||||
2024
Q2 | $1.13B | Sell |
|
|||||
2024
Q1 | $1.08B | Buy |
|
|||||
2023
Q4 | $952M | Buy |
|
|||||
2023
Q3 | $577M | Buy |
|
|||||
2023
Q2 | $505M | Buy |
|
|||||
2023
Q1 | $431M | Sell |
|
|||||
2022
Q4 | $400M | Sell |
|
|||||
2022
Q3 | $870M | Buy |
|
|||||
2022
Q2 | $462M | Sell |
|
|||||
2022
Q1 | $471M | Sell |
|
|||||
2021
Q4 | $437M | Sell |
|
|||||
2021
Q3 | $387M | Sell |
|
|||||
2021
Q2 | $865M | Sell |
|
|||||
2021
Q1 | $969M | Buy |
|
|||||
2020
Q4 | $985M | Buy |
|
|||||
2020
Q3 | $517M | Sell |
|
|||||
2020
Q2 | $570M | Buy |
|
|||||
2020
Q1 | $445M | Sell |
|
|||||
2019
Q4 | $467M | Buy |
|
|||||
2019
Q3 | $317M | Buy |
|
|||||
2019
Q2 | $193M | Buy |
|
|||||
2019
Q1 | $141M | Sell |
|
|||||
2018
Q4 | $146M | Buy |
|
|||||
2018
Q3 | $99.1M | Sell |
|
|||||
2018
Q2 | $138M | Sell |
|
|||||
2018
Q1 | $139M | Sell |
|
|||||
2017
Q4 | $176M | Buy |
|
|||||
2017
Q3 | $90M | Buy |
|
|||||
2017
Q2 | $57.9M | Buy |
|
|||||
2017
Q1 | $3.8M | Hold |
|
|||||
2016
Q4 | $2.56M | Buy |
|
|||||
2016
Q3 | $2.71M | Hold |
|
|||||
2016
Q2 | $2.67M | Hold |
|
|||||
2016
Q1 | $2.47M | Hold |
|
|||||
2015
Q4 | $3.91M | Sell |
|
|||||
2015
Q3 | $15.6M | Hold |
|
|||||
2015
Q2 | $18.6M | Sell |
|
|||||
2015
Q1 | $17.9M | Buy |
|
|||||
2014
Q4 | $3.9M | Buy |
|
|||||
2014
Q3 | $3.59M | Hold |
|
|||||
2014
Q2 | $3.03M | Hold |
|
|||||
2014
Q1 | $2.26M | Buy |
|
|||||
2013
Q4 | $2.01M | Hold |
|
|||||
2013
Q3 | $2.05M | Hold |
|
|||||
2013
Q2 | $2.18M | Buy |
|